- Home
- NTZ vs RANI Comparison
NTZ vs RANI Comparison
Compare NTZ & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- RANI
- Stock Information
- Founded
- NTZ 1959
- RANI 2012
- Country
- NTZ Italy
- RANI United States
- Employees
- NTZ N/A
- RANI N/A
- Industry
- NTZ Home Furnishings
- RANI Medicinal Chemicals and Botanical Products
- Sector
- NTZ Consumer Discretionary
- RANI Health Care
- Exchange
- NTZ Nasdaq
- RANI Nasdaq
- Market Cap
- NTZ 29.4M
- RANI 24.2M
- IPO Year
- NTZ 1993
- RANI 2021
- Fundamental
- Price
- NTZ $2.67
- RANI $1.90
- Analyst Decision
- NTZ
- RANI Strong Buy
- Analyst Count
- NTZ 0
- RANI 6
- Target Price
- NTZ N/A
- RANI $8.67
- AVG Volume (30 Days)
- NTZ 2.7K
- RANI 21.6M
- Earning Date
- NTZ 04-13-2023
- RANI 11-06-2025
- Dividend Yield
- NTZ N/A
- RANI N/A
- EPS Growth
- NTZ N/A
- RANI N/A
- EPS
- NTZ N/A
- RANI N/A
- Revenue
- NTZ $337,653,480.00
- RANI $1,200,000.00
- Revenue This Year
- NTZ N/A
- RANI N/A
- Revenue Next Year
- NTZ N/A
- RANI N/A
- P/E Ratio
- NTZ N/A
- RANI N/A
- Revenue Growth
- NTZ N/A
- RANI N/A
- 52 Week Low
- NTZ $2.15
- RANI $0.39
- 52 Week High
- NTZ $6.27
- RANI $3.87
- Technical
- Relative Strength Index (RSI)
- NTZ 37.97
- RANI 54.20
- Support Level
- NTZ $2.61
- RANI $1.77
- Resistance Level
- NTZ $3.15
- RANI $2.16
- Average True Range (ATR)
- NTZ 0.08
- RANI 0.35
- MACD
- NTZ -0.03
- RANI -0.07
- Stochastic Oscillator
- NTZ 9.38
- RANI 41.74
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.